Faculty Recruitment at Gangamai College of Pharmacy | 18 posts

The North Maharashtra University, Jalgaon, established on 15th August, 1990 under the Maharashtra Universities Act, XXIX of 1989, started its academic and administrative functioning from the academic year 1991-92. Within the span of 3 years, the University is recognized under section 2 (f) in 1991 and 12 (B) in 1994 under the University Grants Commission (UGC) Act, 1956. The jurisdiction of the University is extended over three districts i.e. Jalgaon, Dhule and Nandurbar, a pre-dominantly tribal and rural area of Khandesh region.

Applications are invited for the following posts. The eligible candidate should submit their application within 15 days from the date of publication of this advertisement to the above college address


About Authors:
Rahul .S.Marathe* , Prof.Mrs.M.S.Patil
A.R.Ajmera College Of Pharmacy,
Nagaon, Dhule (MS)

Attention deficit hyperactivity disorder (ADHD) is one of the most common childhood disorders and can continue through adolescence and adulthood. Symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and hyperactivity (over activity). The disorder is commonly occurred in 3 to 7 out of every 100 school-aged children. ADHD is commonly perceived as a childhood disorder, but it persists into adulthood in 35% to 70% of affected people.
Symptoms occur at an early age, occur in most areas of a child’s life, and persist over time, frequently into adulthood The precise constellation of symptoms changes as children grow and develop.With proper medication and handling the child can grow up to be a vibrant, active and successful adult. Not all children and youth havethe same type of ADHD. Some may be hyperactive. Others maybe under-active. Some may have great problems with attention. Others may be mildly inattentive but overly impulsive.


About Authors:
Wagh Vinod. T.
Dept. of Pharmaceutics,
DCS’s. A.R.A. College of Pharmacy, Nagaon,
Dhule-424005 MH. India

The simple and accurate method of analysis to determine Glimepiride (GLM), Pioglitazone hydrochloride (PIO) and Metformin hydrochloride (MET) in combined dosage forms was developed using second-derivative spectrophotometry and. GLM, PIO and MET in combined preparations (tablets) were quantified using the second-derivative responses at 233.4 nm for GLM, 265.4 nm for PIO and 252.6 nm for MET in spectra of their solutions in methanol. The calibration curves were linear [correlation coefficient (r) = 0.9990 for GLM, 0.9990 for PIO and 0.9990 for MET] in the concentration range of 5-25 g/ml for GLM, 5- 25 g/ml for PIO and 2- 12 g/ml for MET. The method was validated and found to be accurate, precise, and specific. The method was successfully applied to the estimation of GLM, PIO and MET in combined tablet formulations.